213 related articles for article (PubMed ID: 36499391)
1. Investigating SH-SY5Y Neuroblastoma Cell Surfaceome as a Model for Neuronal-Targeted Novel Therapeutic Modalities.
Gangras P; Gelfanova V; Williams GD; Handelman SK; Smith RM; Debets MF
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499391
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic Profiling Discloses Molecular and Cellular Events Related to Neuronal Differentiation in SH-SY5Y Neuroblastoma Cells.
Pezzini F; Bettinetti L; Di Leva F; Bianchi M; Zoratti E; Carrozzo R; Santorelli FM; Delledonne M; Lalowski M; Simonati A
Cell Mol Neurobiol; 2017 May; 37(4):665-682. PubMed ID: 27422411
[TBL] [Abstract][Full Text] [Related]
3. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
4. Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-
Leung TCN; Lu SN; Chu CN; Lee J; Liu X; Ngai SM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256121
[TBL] [Abstract][Full Text] [Related]
5. 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach.
Magalingam KB; Somanath SD; Ramdas P; Haleagrahara N; Radhakrishnan AK
J Mol Neurosci; 2022 May; 72(5):1026-1046. PubMed ID: 35258800
[TBL] [Abstract][Full Text] [Related]
6. Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.
Shipley MM; Mangold CA; Kuny CV; Szpara ML
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956768
[TBL] [Abstract][Full Text] [Related]
7. SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability.
Bell M; Zempel H
Rev Neurosci; 2022 Jan; 33(1):1-15. PubMed ID: 33866701
[TBL] [Abstract][Full Text] [Related]
8. Protein profiling of SH-SY5Y neuroblastoma cells: The effect of rhein.
Cockova Z; Ujcikova H; Telensky P; Novotny J
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502566
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of the Muscarinic Acetylcholine Type 1 Receptor Enhances Mitochondrial Membrane Potential and Expression of Respiratory Chain Components via AMPK in Human Neuroblastoma SH-SY5Y Cells and Primary Neurons.
Naznin F; Waise TMZ; Fernyhough P
Mol Neurobiol; 2022 Nov; 59(11):6754-6770. PubMed ID: 36002781
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma SH-SY5Y Cell Differentiation to Mature Neuron by AM580 Treatment.
Cai A; Lin Z; Liu N; Li X; Wang J; Wu Y; Gao K; Jiang Y
Neurochem Res; 2022 Dec; 47(12):3723-3732. PubMed ID: 36066699
[TBL] [Abstract][Full Text] [Related]
11. Cellular and sub-cellular Cu isotope fractionation in the human neuroblastoma SH-SY5Y cell line: proliferating versus neuron-like cells.
Costas-Rodríguez M; Colina-Vegas L; Solovyev N; De Wever O; Vanhaecke F
Anal Bioanal Chem; 2019 Jul; 411(19):4963-4971. PubMed ID: 31093701
[TBL] [Abstract][Full Text] [Related]
12. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
Kovalevich J; Santerre M; Langford D
Methods Mol Biol; 2021; 2311():9-23. PubMed ID: 34033074
[TBL] [Abstract][Full Text] [Related]
13. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
14. Transformation of SH-SY5Y cell line into neuron-like cells: Investigation of electrophysiological and biomechanical changes.
Şahin M; Öncü G; Yılmaz MA; Özkan D; Saybaşılı H
Neurosci Lett; 2021 Feb; 745():135628. PubMed ID: 33440235
[TBL] [Abstract][Full Text] [Related]
15. Degree of differentiation impacts neurobiological signature and resistance to hypoxia of SH-SY5Y cells.
Voogd EJHF; Doorn N; Levers MR; Hofmeijer J; Frega M
J Neural Eng; 2024 Jan; 20(6):. PubMed ID: 38128130
[No Abstract] [Full Text] [Related]
16. Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.
Coccini T; Vecchio S; Crevani M; De Simone U
Neurotox Res; 2019 Jan; 35(1):49-62. PubMed ID: 29934755
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis identifies proteins and pathways related to neuronal development in differentiated SH-SY5Y neuroblastoma cells.
Murillo JR; Goto-Silva L; Sánchez A; Nogueira FCS; Domont GB; Junqueira M
EuPA Open Proteom; 2017 Sep; 16():1-11. PubMed ID: 29900121
[TBL] [Abstract][Full Text] [Related]
18. Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State.
Jantas D; Grygier B; Zatorska J; Lasoń W
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):443-451. PubMed ID: 29753314
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression and cytoplasmic compartmentalization of ATM protein in differentiated human neuron-like SH-SY5Y cells.
Boehrs JK; He J; Halaby MJ; Yang DQ
J Neurochem; 2007 Jan; 100(2):337-45. PubMed ID: 17241156
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Effects of Acitretin on Human Neuronal SH-SY5Y Cells.
Cai A; Liu N; Lin Z; Li X; Wang J; Wu Y; Gao K; Jiang Y
Neurochem Res; 2023 Jan; 48(1):72-81. PubMed ID: 35987975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
